BCL6 BTB‐specific inhibition via FX1 treatment reduces Tfh cells and reverses lymphoid follicle hyperplasia in Indian rhesus macaque (Macaca mulatta)
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Medical Primatology"
DOI: 10.1111/jmp.12438
Abstract: The BTB domain of B‐cell lymphoma 6 (BCL6) protein was identified as a therapeutic target for B‐cell lymphoma. This study compared the pharmacokinetics (PK) of the BCL6 BTB inhibitor (FX1) between mice and macaques, as… read more here.
Keywords: btb; specific inhibition; bcl6 btb; btb specific ... See more keywords